CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BIO-TECHNE Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BIO-TECHNE Corp
614 Mckinley Pl N E, Suite 1500
Phone: (612) 379-8854p:612 379-8854 MINNEAPOLIS, MN  55413  United States Ticker: TECHTECH
Business Summary
Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, advanced tissue-based in-situ hybridization assays and instrumentation for spatial genomic and tissue biopsy analysis and genetic and oncology kits for research and clinical applications. Its product portfolio and application enable scientific investigations into biological processes and molecular diagnostics and progression of specific diseases.
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20256/30/2025YesYes--Yes

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
2835 In vitro and in vivo diagnostic substances
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
CFO DEAN HARRIMAN .HARRIMAN
Independent Chairman of the Board Robert V.Baumgartner 69 11/2/2012 8/12/2003
President, Chief Executive Officer, Director KimKelderman 58 2/1/2024 4/30/2018
9 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Bio-Techne Ltd. 19 Barton Lane Abingdon Science Park United Kingdom
Tocris Bioscience Hung Road Bristol United Kingdom
Lunaphore Technologies SA Route de Lully 5C Tolochenaz Switzerland
14 additional Subsidiary records available in full report.

Business Names
Business Name
Advanced Cell Diagnostics, Inc.
Asuragen, Inc.
Atlanta Biologicals, Inc.
21 additional Business Names available in full report.

General Information
Number of Employees: 3,100 (As of 6/30/2025)
Outstanding Shares: 155,693,441 (As of 9/5/2025)
Shareholders: 170,000
Stock Exchange: NASD
Federal Tax Id: 411427402
Fax Number: (612) 656-4400
Email Address: info@rndsystems.com


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, October 18, 2025